Riskpilot← Back to searchSign inGet full accessMedivox AB
ABActiveOrg 5595463034Medical specialists activities · NACE 8622Est. 20250 employees
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
0 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Medivox AB
Org number
5595463034
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 september 2025
Share capital
—
Employees
0
VAT registered
Yes
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Läkarkonsultverksamhet med fokus inom öron-, näs- och halssjukvård samt foniatri, innefattande konsultationer, medicinska utredningar, behandling, rådgivning, utbildning och forskning.Därutöver får bolaget utveckla medicinska metoder och produkter, bedriva föreläsnings- och författarverksamhet samt äga och förvalta fast och lös egendom, inklusive värdepapper.
Address
Email
claes_henrik@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item |
|---|
| Revenue |
| Staff expenses |
| EBITDA |
| Depreciation & amort. |
| EBIT |
| Net financials |
| Profit before tax |
| Tax |
| Net profit |
| Item |
|---|
| Total assets |
| Equity |
| Long-term debt |
| Short-term debt |
| Total debt |
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EC Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medivox AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Claes-Henrik Berg | Chief Executive Officer | 0 companies |
| Linn Hanna Gabriella Persson Berg | Deputy Board Member | 0 companies |